Targeting B-cells in Cerebral Spinal Fluid May Lead to More Effective Therapies for MS

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses targeting B-cells in Cerebral Spinal Fluid, may lead to more effective therapies for MS. Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, reads from her DISabled to ENabled column entitled Using Social Media To Challenge Perceptions About Disability.=====================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.http://ChangesInRMS.com=====================================Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/